Supporting this assumption, in vitro and in vivo animal studies have shown that enhanced ATP signaling via P2X7 receptor activation leads to oligodendrocytes excitotoxicity and death, resulting in tissue damage that highly resembles MS lesions. The gene discussed is P2RX7; the disease is myeloid sarcoma.